The purpose of this study was to determine whether estrogen modulates the f
unction of vascular melatonin receptors. We used the rat caudal artery and
found that the contractile effects of melatonin were influenced by the estr
ous cycle, ovariectomy, and estrogen replacement. In arterial ring segments
isolated from female rats, melatonin potentiated, in a concentration-depen
dent manner, contractions produced either by adrenergic nerve stimulation o
r by phenylephrine. Constrictor responses to melatonin were smaller in arte
ries from female rats in proestrus compared with other stages of the estrou
s cycle and after ovariectomy. Administration of 17 beta-estradiol to ovari
ectomized female rats also resulted in decreased constriction of isolated a
rteries to melatonin; however, in vitro addition of 17 beta-estradiol (10(-
7) M) had no effect. In the caudal artery, melatonin appears to act on two
receptor subtypes that, mediate contraction and relaxation, respectively. T
he selective melatonin MT2-receptor antagonist 4-phenyl-2-propionamidotetra
line (4P-PDOT) enhanced constrictor responses to melatonin in arterial segm
ents from intact female rats, consistent with the inhibition of MT2 recepto
r-mediated relaxation. In contrast, 4P-PDOT had no significant effect in ar
teries from ovariectomized female fats. However, when estradiol was replace
d in vivo, the effect of 4P-PDOT on melatonin responses was restored. Thus
circulating estradiol appears to enhance MT2 melatonin-receptor function in
the thermoregulatory caudal artery of the female rat resulting in increase
d vasodilatation in response to melatonin.